Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers-Reference-Cited by-同舟云学术

Cetuximab resistance induced by hepatocyte growth factor is overcome by MET inhibition in KRAS, NRAS, and BRAF wild-type colorectal cancers

Published:2021-12-01 Issue: Volume: Page:
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

Kim Sang-A,Park Hyejoo,Kim Kui-Jin^ORCID,Kim Ji-Won^ORCID,Sung Ji Hea,Nam Milang,Lee Ju Hyun,Jung Eun Hee,Suh Koung Jin,Lee Ji Yun,Kim Se Hyun,Lee Jeong-Ok,Kim Jin Won,Kim Yu Jung,Kim Jee Hyun,Bang Soo-Mee,Lee Jong Seok,Lee Keun-Wook

Funder

Seoul National University Hospital

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-021-03872-4.pdf

Reference24 articles.

1. Bardelli A, Corso S, Bertotti A, Hobor S, Valtorta E, Siravegna G, Siena S (2013) Amplification of the MET receptor drives resistance to anti-EGFR therapies in colorectal cancer. Cancer Discov 3(6):658–673. https://doi.org/10.1158/2159-8290.CD-12-0558

2. Benson AB, Venook AP, Al-Hawary MM, Arain MA, Chen YJ, Ciombor KK, Gurski LA (2021) Colon cancer, version 22021, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw 19(3):329–359. https://doi.org/10.6004/jnccn.2021.0012

3. Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R, Verweij J (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247. https://doi.org/10.1016/j.ejca.2008.10.026

4. Ghandi M, Huang FW, Jane-Valbuena J, Kryukov GV, Lo CC, McDonald ER 3rd, Sellers WR (2019) Next-generation characterization of the cancer cell line encyclopedia. Nature 569(7757):503–508. https://doi.org/10.1038/s41586-019-1186-3

5. Hu HJ, Lin XL, Liu MH, Fan XJ, Zou WW (2016) Curcumin mediates reversion of HGF-induced epithelial-mesenchymal transition via inhibition of c-Met expression in DU145 cells. Oncol Lett 11(2):1499–1505. https://doi.org/10.3892/ol.2015.4063

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overcoming Resistance to Standard-of-Care Therapies for Head and Neck Squamous Cell Carcinomas;Cells;2024-06-11

2. Inhibition of autocrine HGF maturation overcomes cetuximab resistance in colorectal cancer;Cellular and Molecular Life Sciences;2024-01-12

3. Deciphering treatment resistance in metastatic colorectal cancer: roles of drug transports, EGFR mutations, and HGF/c-MET signaling;Frontiers in Pharmacology;2024-01-10

4. Exosomes derived from MDR cells induce cetuximab resistance in CRC via PI3K/AKT signaling‑mediated Sox2 and PD‑L1 expression;Experimental and Therapeutic Medicine;2023-01-04

5. ACY1 Downregulation Enhances the Radiosensitivity of Cetuximab-Resistant Colorectal Cancer by Inactivating the Wnt/β-Catenin Signaling Pathway;Cancers;2022-11-21